BioSpace News Archive

Roche announced that it will be showcasing next generation diagnostics solutions that will deliver fast and accurate results to help clinicians improve patient care and help reduce the healthcare burden at the 24th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicines in Munich, Germany.

Artios Pharma Limited announces that the development of its ataxia telangiectasia and Rad3-related Inhibitor, ART0380, has progressed into a Phase 1b dose expansion study targeting ATM deficient tumors.

RaySearch’s CFO, Torbjörn Wingårdh, leaves RaySearch effective immediately. The process to recruit a new CFO has been initiated.

Imara Inc. announced results from interim analyses of its Ardent Phase 2b clinical trial of tovinontrine in patients with sickle cell disease and Forte Phase 2b clinical trial of tovinontrine in patients with beta-thalassemia.

Bristol Myers Squibb announced that the European Commission has approved Opdivo for the adjuvant treatment of adults with muscle-invasive urothelial carcinoma with tumor cell PD-L1 expression ≥1% who are at a high risk of recurrence after undergoing radical resection.

BiondVax Pharmaceuticals Ltd., a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, announced that the Company will host an analyst and investors webinar event tomorrow, April 6th, in Hebrew.

Bristol Myers Squibb announced that the European Commission has approved Opdivo in combination with fluoropyrimidine- and platinum-based chemotherapy for the first-line treatment of adult patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma with tumor cell PD-L1 expression ≥ 1%.

Cara Therapeutics, Inc. announced that Christopher Posner, President and Chief Executive Officer, will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Monday, April 11, 2022, at 1:30 p.m. ET.

Plus Therapeutics, Inc. announced that it has expanded its partnership with Medidata, a Dassault Systèmes company.

Eliem Therapeutics, Inc. announced the strengthening of its executive team with the appointment of Susan Franks, MS as Eliem’s Senior Vice President and Head of Regulatory Affairs.